Geode Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $33.1K | Buy |
|
|||||
|
2023
Q2 | $9.29K | Sell |
|
|||||
|
2023
Q1 | $27.2K | Hold |
|
|||||
|
2022
Q4 | $21K | Hold |
|
|||||
|
2022
Q3 | $26K | Hold |
|
|||||
|
2022
Q2 | $75K | Buy |
|
|||||
|
2022
Q1 | $76K | Hold |
|
|||||
|
2021
Q4 | $97K | Hold |
|
|||||
|
2021
Q3 | $170K | Hold |
|
|||||
|
2021
Q2 | $177K | Buy |
|
|||||
|
2021
Q1 | $151K | Hold |
|
|||||
|
2020
Q4 | $161K | Hold |
|
|||||
|
2020
Q3 | $202K | Buy |
|
|||||
|
2020
Q2 | $153K | Buy |
|
|||||
|
2020
Q1 | $27K | Hold |
|
|||||
|
2019
Q4 | $45K | Hold |
|
|||||
|
2019
Q3 | $24K | Hold |
|
|||||
|
2019
Q2 | $22K | Sell |
|
|||||
|
2019
Q1 | $99K | Hold |
|
|||||
|
2018
Q4 | $73K | Hold |
|
|||||
|
2018
Q3 | $166K | Hold |
|
|||||
|
2018
Q2 | $164K | Hold |
|
|||||
|
2018
Q1 | $259K | Hold |
|
|||||
|
2017
Q4 | $258K | Hold |
|
|||||
|
2017
Q3 | $298K | Hold |
|
|||||
|
2017
Q2 | $367K | Hold |
|
|||||
|
2017
Q1 | $415K | Hold |
|
|||||
|
2016
Q4 | $452K | Hold |
|
|||||
|
2016
Q3 | $659K | Hold |
|
|||||
|
2016
Q2 | $382K | Sell |
|
|||||
|
2016
Q1 | $779 | Buy |
|
|||||
|
2015
Q4 | $1.08M | Buy |
|
|||||
|
2015
Q3 | $1.78M | Buy |
|
|||||
|
2015
Q2 | $1.2M | Buy |
|
|||||
|
2015
Q1 | $1.18M | Hold |
|
|||||
|
2014
Q4 | $1.4M | Buy |
|
|||||
|
2014
Q3 | $915K | Buy |
|
|||||
|
2014
Q2 | $991K | Buy |
|
|||||
|
2014
Q1 | $1.18M | Buy |
|
|||||
|
2013
Q4 | $1.27M | Buy |
|
|||||
|
2013
Q3 | $1.39M | Buy |
|
|||||
|
2013
Q2 | $1.35M | Buy |
|